Based on the measurements of operating efficiency obtained from Rezolute's historical financial statements, Rezolute is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December. At this time, Rezolute's Non Current Liabilities Total is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 473 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 34.3 K in 2024. Key indicators impacting Rezolute's financial strength include:
The essential information of the day-to-day investment outlook for Rezolute includes many different criteria found on its balance sheet. An individual investor should monitor Rezolute's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Rezolute.
Net Income
(65.04 Million)
Rezolute
Select Account or Indicator
Market Cap
Enterprise Value
Ptb Ratio
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Capex To Depreciation
Pb Ratio
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Ebt Per Ebit
Effective Tax Rate
Company Equity Multiplier
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Days Of Inventory Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Return On Assets
Price Fair Value
Return On Equity
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Inventory
Stock Based Compensation
Total Cashflows From Investing Activities
Change To Account Receivables
Other Cashflows From Investing Activities
Change To Liabilities
Sale Purchase Of Stock
Net Borrowings
Change To Operating Activities
Change To Netincome
Investments
Issuance Of Capital Stock
Total Assets
Total Current Liabilities
Total Stockholder Equity
Net Debt
Retained Earnings
Accounts Payable
Cash
Cash And Short Term Investments
Common Stock Total Equity
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Stockholder Equity
Total Liab
Total Current Assets
Common Stock
Short Long Term Debt Total
Other Current Liab
Property Plant And Equipment Net
Current Deferred Revenue
Non Current Assets Total
Non Currrent Assets Other
Inventory
Other Current Assets
Property Plant And Equipment Gross
Short Term Debt
Intangible Assets
Property Plant Equipment
Other Liab
Net Tangible Assets
Other Assets
Short Long Term Debt
Accumulated Other Comprehensive Income
Long Term Debt
Short Term Investments
Deferred Long Term Liab
Capital Lease Obligations
Net Invested Capital
Non Current Liabilities Other
Net Working Capital
Capital Stock
Depreciation And Amortization
Interest Expense
Selling General Administrative
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Research Development
Net Income From Continuing Ops
Net Income Applicable To Common Shares
Net Interest Income
Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Rezolute Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Rezolute's financial statements are interrelated, with each one affecting the others. For example, an increase in Rezolute's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Rezolute's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Rezolute. Check Rezolute's Beneish M Score to see the likelihood of Rezolute's management manipulating its earnings.
Rezolute Stock Summary
Rezolute competes with Eledon Pharmaceuticals, Clene, and Larimar Therapeutics. Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California. Rezolute operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 42 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
The reason investors look at the income statement is to determine what Rezolute's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Rezolute's current stock value. Our valuation model uses many indicators to compare Rezolute value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rezolute competition to find correlations between indicators driving Rezolute's intrinsic value. More Info.
Rezolute is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . At this time, Rezolute's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Rezolute by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Rezolute Systematic Risk
Rezolute's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Rezolute volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Rezolute correlated with the market. If Beta is less than 0 Rezolute generally moves in the opposite direction as compared to the market. If Rezolute Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Rezolute is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Rezolute is generally in the same direction as the market. If Beta > 1 Rezolute moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Rezolute Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rezolute's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Rezolute growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Rezolute help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Rezolute. We use our internally-developed statistical techniques to arrive at the intrinsic value of Rezolute based on widely used predictive technical indicators. In general, we focus on analyzing Rezolute Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Rezolute's daily price indicators and compare them against related drivers.
When running Rezolute's price analysis, check to measure Rezolute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rezolute is operating at the current time. Most of Rezolute's value examination focuses on studying past and present price action to predict the probability of Rezolute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rezolute's price. Additionally, you may evaluate how the addition of Rezolute to your portfolios can decrease your overall portfolio volatility.